1 of 1
Story summary
- Stanford University researchers find strong evidence linking the Epstein-Barr virus (EBV) to systemic lupus erythematosus (SLE).
- EBV can infect and reprogram immune cells, particularly B cells, triggering SLE in genetically susceptible individuals.
- In SLE patients, about 25 times more B cells are infected with EBV than in healthy individuals.
- The findings could support antiviral treatments and CAR T-cell therapy, prompting further study and vaccine exploration.
